Skandinaviska Enskilda Banken AB publ Makes New $1.01 Million Investment in Tempus AI, Inc. (NASDAQ:TEM)

Key Points

• Skandinaviska Enskilda Banken AB publ has invested $1.01 million in Tempus AI, acquiring approximately 20,978 shares during the 1st quarter, reflecting growing institutional interest in the company.
• Tempus AI's CEO, Eric P. Lefkofsky, sold 250,000 shares valued at over $17 million, indicating a **2.60% decrease** in his ownership, while insiders collectively sold over **612,000 shares** in the last three months.
• Tempus AI reported a quarterly revenue increase of **75.4% year-over-year**, exceeding analysts' expectations, and posted an earnings per share of **($0.24)**, beating the consensus estimate by $0.03.

Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The fund purchased 20,978 shares of the company's stock, valued at approximately $1,012,000.

Several other large investors also recently added to or reduced their stakes in the business. Cherry Tree Wealth Management LLC purchased a new stake in shares of Tempus AI during the first quarter worth about $31,000. Operose Advisors LLC bought a new stake in shares of Tempus AI in the 4th quarter worth $25,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after buying an additional 400 shares during the last quarter. Continuum Advisory LLC bought a new position in Tempus AI during the 1st quarter valued at about $39,000. Finally, Signaturefd LLC bought a new position in Tempus AI during the first quarter valued at approximately $48,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Trading Down 0.8%

Shares of TEM stock traded down $0.48 during trading hours on Wednesday, reaching $57.81. 7,183,082 shares of the stock were exchanged, compared to its average volume of 8,120,242. The firm has a market capitalization of $10.01 billion and a price-to-earnings ratio of -7.41. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $91.45. The company's 50-day moving average price is $62.68 and its 200-day moving average price is $56.96. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The firm had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. The business's quarterly revenue was up 75.4% on a year-over-year basis. As a group, equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on TEM. Bank of America lifted their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. BTIG Research assumed coverage on Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 price objective for the company. Morgan Stanley boosted their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Guggenheim raised their price objective on Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research report on Monday, June 30th. Finally, Piper Sandler lifted their price objective on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Tempus AI has a consensus rating of "Moderate Buy" and a consensus target price of $65.09.

Insider Activity at Tempus AI

In other Tempus AI news, Director Theodore Leonsis sold 205,847 shares of the stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the transaction, the director directly owned 15,511 shares in the company, valued at $1,049,474.26. This represents a 92.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business's stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $62.87, for a total transaction of $10,452,137.50. Following the completion of the transaction, the chief executive officer directly owned 9,274,033 shares of the company's stock, valued at $583,058,454.71. This trade represents a 1.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 778,772 shares of company stock worth $52,052,375 over the last ninety days. 27.60% of the stock is currently owned by company insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.